Khaliullin, F.A.,
Klen, E.E.,
Nikitina, I.L.,
Pavlov, V.N.,
Rozit, G.A.,
Gaisina, G.G.,
Samorodov, A.V. (2023) . An in vivo study of the
antidepressant activity revealed the promising compound 1-(1,1-dioxidothietan-3-yl)-4
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) bioavailability. The compounds exhibited varying degrees of
antidepressant activity after a single intraperitoneal
Khaliullin, F. A.,
Klen, E. E.,
Nikitina, I. L.,
Pavlov, V. N.,
Rozit, G. A.,
Gaisina, G. G.,
Samorodov, A. V. (2023) . An in vivo
study of the
antidepressant activity revealed the promising compound 1-(1,1-dioxidothietan-3-yl)-4
-substituted thietane-1,1-dioxide derivative (N-199/1) exhibiting
antidepressant properties, in several tests
-crown-6 ether in toluene. In vitro anticoagulant and antiplatelet
activity of the adduct was studied
Faizullina, L. Kh.,
Karamisheva, L. Sh.,
Yakupova, L. R.,
Migranov, A. R.,
Saifullin, R. L.,
Valeev, F. A.,
Valiullina, Z. A.,
Samorodov, A. V. (2024) synthesized in one step. The antioxidant, anticoagulation, and antiaggregation
activities of the obtained
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the antiplatelet, anticoagulant, and antioxidant
activity revealed promising compounds
Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) The main goal of applying antiplatelet drugs is a reduced probability of thrombosis so that
active